UniSa - IRIS Institutional Research Information System

ERRO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.149
NA - Nord America 6.015
EU - Europa 2.595
SA - Sud America 541
OC - Oceania 64
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.410
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 6.733
US - Stati Uniti d'America 5.908
SG - Singapore 1.011
IT - Italia 685
CN - Cina 569
RU - Federazione Russa 499
BR - Brasile 487
UA - Ucraina 356
IE - Irlanda 308
TR - Turchia 277
DE - Germania 241
KR - Corea 198
VN - Vietnam 198
SE - Svezia 179
GB - Regno Unito 86
FI - Finlandia 74
CA - Canada 63
IN - India 60
EE - Estonia 36
AU - Australia 35
NL - Olanda 31
NZ - Nuova Zelanda 28
AT - Austria 26
MX - Messico 23
BD - Bangladesh 20
AR - Argentina 19
IQ - Iraq 17
PL - Polonia 17
CZ - Repubblica Ceca 13
JP - Giappone 13
ZA - Sudafrica 13
ES - Italia 9
FR - Francia 9
UZ - Uzbekistan 9
VE - Venezuela 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
DZ - Algeria 6
ID - Indonesia 6
KE - Kenya 6
BE - Belgio 5
CL - Cile 5
IR - Iran 5
PY - Paraguay 5
DO - Repubblica Dominicana 4
EC - Ecuador 4
GR - Grecia 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
NP - Nepal 4
PK - Pakistan 4
BO - Bolivia 3
CI - Costa d'Avorio 3
EG - Egitto 3
IL - Israele 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
ET - Etiopia 2
EU - Europa 2
KW - Kuwait 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
RW - Ruanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 18.410
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.731
Ann Arbor 1.219
Princeton 848
Chandler 538
Wilmington 494
Jacksonville 427
Singapore 373
Dublin 300
Izmir 265
Ashburn 222
Woodbridge 216
Houston 190
Salerno 186
Dong Ket 162
Moscow 152
Andover 127
Pellezzano 121
Beijing 118
Nanjing 115
Dallas 100
Naples 98
Boardman 69
Norwalk 69
Fairfield 62
Munich 53
Los Angeles 49
Düsseldorf 44
Shenyang 43
Nuremberg 41
The Dalles 37
Hebei 36
Tallinn 36
São Paulo 35
Nanchang 34
Pune 34
Dearborn 29
Changsha 28
Council Bluffs 28
Columbus 27
Mestre 27
West Jordan 27
Jiaxing 26
San Diego 23
Redwood City 22
Seattle 21
Turku 20
Belo Horizonte 18
Brasília 18
Brooklyn 18
London 18
New York 18
Washington 17
Ho Chi Minh City 16
Rome 16
Boston 15
Cambridge 15
Rio de Janeiro 15
San Francisco 15
Sydney 15
Amsterdam 14
Lecce 14
Montreal 14
Santa Clara 14
Tianjin 14
Warsaw 14
Auckland 13
Guangzhou 13
Stockholm 13
Falls Church 12
Toronto 11
Brno 10
Chicago 10
Fort Worth 10
Johannesburg 10
Orange 10
Baghdad 9
Curitiba 9
Lappeenranta 9
Tashkent 9
Jinan 8
Milan 8
Phoenix 8
Tokyo 8
Vienna 8
Chennai 7
Melbourne 7
Shanghai 7
Assago 6
Atlanta 6
Carapicuíba 6
Dormagen 6
Fortaleza 6
Guarulhos 6
Nairobi 6
Brussels 5
Casoria 5
Genoa 5
Goiânia 5
Hanoi 5
Perugia 5
Totale 14.501
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.147
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 832
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 793
Sex Differences in Parkinson’s Disease: From Bench to Bedside 329
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 280
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 271
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 261
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 237
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 231
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 225
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 221
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 219
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 213
Non-invasive brain stimulation for dystonia: therapeutic implications 205
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 192
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 185
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 179
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 175
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 174
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 160
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 154
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 154
ADCY5 mutations are another cause of benign hereditary chorea 143
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 141
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 135
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 133
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 131
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 129
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 123
Increased bilirubin levels in de novo Parkinson's disease 118
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 117
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 116
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 111
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 109
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 108
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 106
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 105
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 105
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 104
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 102
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 97
Malabsorption is uncommon in restless legs syndrome. 96
Machine learning can predict mild cognitive impairment in Parkinson's disease 95
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 95
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 93
On the relationship between side of onset and cognition in Parkinson disease 91
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 90
Quitting smoking: An early non-motor feature of Parkinson's disease? 89
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 89
Early MRI findings in acquired hepatocerebral degeneration. 88
Abnormal eating behaviors in progressive supranuclear palsy. 87
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 87
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 86
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 84
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 84
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 84
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 83
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 83
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 82
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 81
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 81
Uric acid relates to dopamine transporter availability in Parkinson's disease. 80
A novel therapeutic approach for synucleinopathies 79
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 77
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 74
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 73
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 73
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 73
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 72
Non-motor correlates of smoking habits in de novo Parkinson's disease 72
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 70
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 70
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 67
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 66
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 66
The "eye of the tiger" sign in pure akinesia with gait freezing. 65
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 64
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 64
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases 63
Hemi-restless legs syndrome induced by clebopride 63
Orthostatic myoclonus associated with Caspr2 antibodies 63
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 63
Restless legs syndrome is a common feature of adult celiac disease 63
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 62
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 62
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 62
Nutritional habits, risk, and progression of Parkinson disease 62
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials 62
Midbrain MRI assessments in progressive supranuclear palsy subtypes 61
Some New and Unexpected Tauopathies in Movement Disorders 61
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 61
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 60
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation 57
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 54
Totale 13.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021677 0 45 57 11 77 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.997 84 40 50 121 116 342 372 261 452 422 371 366
2025/20267.262 3.066 4.196 0 0 0 0 0 0 0 0 0 0
Totale 18.992